Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-01T15:47:26.128Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention of Healthcare-Associated Clostridium difficile Infection: What Works?

Published online by Cambridge University Press:  02 January 2015

Erik R. Dubberke
Erik R. Dubberke*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
*
660 S Euclid Avenue, PO Box 8051, St. Louis, MO 63110 (edubberk@dom.wustl.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Prevention of Clostridium difficile infection has become extremely important because of increases in its incidence and severity. Unfortunately, efforts at C. difficile infection prevention are hampered by lack of data to support optimal prevention methods, especially for endemic C. difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods.

Type
Supplement Article
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue S1: Papers from the Fifth Decennial International Conference on Healthcare-Associated Infections , November 2010 , pp. S38 - S41
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dubberke, ER, Gerding, DN, Classen, D, et al.Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S81–S92.CrossRefGoogle ScholarPubMed
2.Yokoe, DS, Classen, D. Improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S3–S11.CrossRefGoogle ScholarPubMed
3.Johnson, S, Gerding, DN, Olson, MM, et al.Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88(2):137–140.Google Scholar
4.Fowler, S, Webber, A, Cooper, BS, et al.Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimcrob Chemother 2007;59(5):990–995.CrossRefGoogle ScholarPubMed
5.Pear, SM, Williamson, TH, Bettin, KM, Gerding, DN, Galgiani, JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120(4):272–277.CrossRefGoogle ScholarPubMed
6.Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(Suppl 2):S112–S121.CrossRefGoogle ScholarPubMed
7.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725–2732.CrossRefGoogle ScholarPubMed
8.O'Grady, NP, Alexander, M, Dellinger, EP, et al.Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23(12):759–769.CrossRefGoogle ScholarPubMed
9.Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003;31(7):1959–1963.CrossRefGoogle Scholar
10.Warren, DK, Cosgrove, SE, Diekema, DJ, et al.A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(7):662–669.Google Scholar
11.Abbett, SK, Yokoe, DS, Lipsitz, SR, et al.Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(11):1062–1069.CrossRefGoogle ScholarPubMed
12.Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31(4):995–1000.CrossRefGoogle Scholar
13.Boyce, JM, Ligi, C, Kohan, C, Dumigan, D, Havill, NL. Lack of association between the increased incidence of Clostridium difficile–associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006;27(5):479–483.CrossRefGoogle ScholarPubMed
14.Department of Health and Human Services. HHS Action Plan to Prevent Healthcare-Associated Infections. http://www.hhs.gov/ophs/initiatives/hai/actionplan/index.html. Accessed 31 August 2010.Google Scholar
15.Songer, JG, Trinh, HT, Killgore, GE, Thompson, AD, McDonald, LC, Limbago, BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 2009;15(5):819–821.CrossRefGoogle ScholarPubMed
16.Hellickson, LA, Owens, KL. Cross-contamination of Clostridium difficile spores on bed linen during laundering. Am J Infect Control 2007;35(5):E32–E33.Google Scholar
17.Carbone, HL, Hellickson, LA, Thomasser, AL, Vu, LK. Clostrdium difficile cross contamination in the textile laundering process: the importance of selecting an appropriate hard surface disinfectant. In: Program and abstracts of the 5th Decennial International Conference on Healthcare-Associated Infections; March 18–22, 2010; Atlanta, GA. Abstract 160.Google Scholar
18.Clabots, CR, Johnson, S, Olson, MM, Peterson, LR, Gerding, DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166(3): 561–567.CrossRefGoogle ScholarPubMed
19.Dubberke, ER. The, A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis 2009;49(8):1148–1152.CrossRefGoogle ScholarPubMed
20.Dubberke, ER, Yan, Y, Reske, KA, Butler, AM, Fraser, VJ. Development of a Clostridium difficile-associated disease risk prediction model. In: Program and abstracts of the 18th Annual Meeting of the Society for Health-care Epidemiology of America; April 5–8, 2008; Orlando, FL. Abstract 50.Google Scholar
21.Merrigan, MM, Sambol, SP, Johnson, S, Gerding, DN. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Int J Antimicrob Agents 2009;33(Suppl 1):S46–S50.CrossRefGoogle ScholarPubMed
22.Kyne, L, Warny, M, Qamar, A, Kelly, CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342(6):390–397.CrossRefGoogle ScholarPubMed
23.Kyne, L, Warny, M, Qamar, A, Kelly, CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357(9251):189–193.CrossRefGoogle ScholarPubMed
24.Lowy, I, Molrine, DC, Leav, BA, et al.Treatment with monoclonal anti-bodies against Clostridium difficile toxins. N Engl J Med 2010;362(3):197–205.CrossRefGoogle Scholar
25.Sougioultzis, S, Kyne, L, Drudy, D, et al.Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005;128(3): 764–770.CrossRefGoogle ScholarPubMed